
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
Yes, jaundice in newborns is prevalent and usually benign, but these babies still need ongoing clinical assessment. Part 1 reviews ways to identify and categorize hyperbilirubinemia and sets out the testing that a jaundiced infant requires.






